These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37940955)

  • 1. Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study.
    Tan-Lhernould L; Tamandjou C; Deschamps G; Platon J; Sommen C; Chereau F; Parent du Châtelet I; Cauchemez S; Vaux S; Paireau J
    BMC Med; 2023 Nov; 21(1):426. PubMed ID: 37940955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccination and Estimated Public Health Impact in California.
    Tan ST; Park HJ; Rodríguez-Barraquer I; Rutherford GW; Bibbins-Domingo K; Schechter R; Lo NC
    JAMA Netw Open; 2022 Apr; 5(4):e228526. PubMed ID: 35452106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022.
    Rzymski P; Kasianchuk N; Sikora D; Poniedziałek B
    J Med Virol; 2023 Jan; 95(1):e28131. PubMed ID: 36068643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination.
    Fitzpatrick MC; Moghadas SM; Vilches TN; Shah A; Pandey A; Galvani AP
    JAMA Netw Open; 2023 May; 6(5):e2313586. PubMed ID: 37204795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Katikireddi SV; Cerqueira-Silva T; Vasileiou E; Robertson C; Amele S; Pan J; Taylor B; Boaventura V; Werneck GL; Flores-Ortiz R; Agrawal U; Docherty AB; McCowan C; McMenamin J; Moore E; Ritchie LD; Rudan I; Shah SA; Shi T; Simpson CR; Barreto ML; Oliveira VA; Barral-Netto M; Sheikh A
    Lancet; 2022 Jan; 399(10319):25-35. PubMed ID: 34942103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021.
    Machado A; Kislaya I; Rodrigues AP; Sequeira D; Lima J; Cruz C; Leite PP; Matias Dias C; Nunes B
    PLoS One; 2022; 17(9):e0274008. PubMed ID: 36099273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France.
    Tamandjou Tchuem CR; Auvigne V; Vaux S; Montagnat C; Paireau J; Monnier Besnard S; Gabet A; Benhajkassen N; Le Strat Y; Parent Du Chatelet I; Levy-Bruhl D
    Vaccine; 2023 Mar; 41(13):2280-2288. PubMed ID: 36870880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System.
    Semenzato L; Botton J; Baricault B; Deloumeaux J; Joachim C; Sylvestre E; Dray-Spira R; Weill A; Zureik M
    PLoS One; 2022; 17(9):e0274309. PubMed ID: 36084113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans.
    Young-Xu Y; Korves C; Roberts J; Powell EI; Zwain GM; Smith J; Izurieta HS
    JAMA Netw Open; 2021 Oct; 4(10):e2128391. PubMed ID: 34613401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boosters and time from the last anti-COVID-19 vaccine dose: lead public health choices by real-time epidemiological assessment.
    Russo AG; Murtas R; Tunesi S; Decarli A; Bergamaschi W
    Epidemiol Prev; 2022; 46(1-2):34-46. PubMed ID: 35354266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021.
    Sacco C; Mateo-Urdiales A; Petrone D; Spuri M; Fabiani M; Vescio MF; Bressi M; Riccardo F; Del Manso M; Bella A; Pezzotti P;
    Euro Surveill; 2021 Nov; 26(47):. PubMed ID: 34823637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19.
    Cook TM; Roberts JV
    Anaesthesia; 2021 May; 76(5):608-616. PubMed ID: 33572007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections, Hospitalizations, and Deaths Among US Nursing Home Residents With vs Without a SARS-CoV-2 Vaccine Booster.
    McConeghy KW; Bardenheier B; Huang AW; White EM; Feifer RA; Blackman C; Santostefano CM; Lee Y; DeVone F; Halladay CW; Rudolph JL; Zullo AR; Mor V; Gravenstein S
    JAMA Netw Open; 2022 Dec; 5(12):e2245417. PubMed ID: 36477482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021.
    Mendes D; Chapman R; Gal P; Atwell J; Nguyen JL; Hamson L; Di Fusco M; Czudek C; Yang J
    J Med Econ; 2022; 25(1):1039-1050. PubMed ID: 36097853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.